Diagnostic Testing Fund – Pediatric Central Nervous System: Developmental/Epileptic Encephalopathies

This fund supports families of children with seizure disorders or developmental delays by providing access to genetic and biomarker testing. These precision diagnostics help identify underlying conditions such as Dravet syndrome, CDKL5 deficiency, or Lennox-Gastaut syndrome. An accurate diagnosis not only guides personalized treatment plans but also improves access to early interventions, support services, and emerging therapies. Timely testing is especially important in early childhood, when rapid diagnosis can significantly impact developmental outcomes and quality of life.